The strongest nominally significant correlations for both active treatments were with changes in the Risk Avoidance domain (LDX, r = −.44; OROS-MPH, r = −.42) and the Achievement domain (LDX, r = −.36; OROS-MPH r = −.48).
← all excerpts
Correlations Between Clinical Trial Outcomes Based on Symptoms, Functional Impairments, and Quality of Life in Children and Adolescents With ADHD.
1
—
—